Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single- and multicenter trials
Ellingson, Benjamin M., Harris, Robert J., Woodworth, Davis C., Leu, Kevin, Zaw, Okkar, Mason, Warren P., Sahebjam, Solmaz, Abrey, Lauren E., Aftab, Dana T., Schwab, Gisela M., Hessel, Colin, Lai, AlbМова:
english
Журнал:
Neuro-Oncology
DOI:
10.1093/neuonc/now187
Date:
August, 2016
Файл:
PDF, 525 KB
english, 2016
File converter
Більше результатів пошуку
More benefits 
